Related Experiment Video
Updated: Apr 25, 2026

06:24
Author Spotlight: Advancements in iPSCs and Genetic Disease Research
Published on: October 20, 2023
2.0K
[Comparison and analysis between CLL-hBMSC and N-hBMSC]
Huan Wang1, Jun Zhou1, Jing-Jing Xu1
1Central Laboratory, The First Affiliated Hospital of Soochow University, Suzhou 215006, Jiangsu Province,China.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|August 19, 2014
Summary
Human bone marrow stromal cells from chronic lymphocytic leukemia (CLL-hBMSC) patients and healthy donors exhibit similar characteristics. These cells do not statistically differ in their ability to support CLL cell survival, suggesting comparable microenvironments.
Area of Science:
- Hematology
- Oncology
- Cell Biology
Background:
- Chronic lymphocytic leukemia (CLL) microenvironment plays a crucial role in disease progression.
- Human bone marrow stromal cells (hBMSC) are key components of this microenvironment.
- Understanding the differences and similarities between CLL-hBMSC and normal hBMSC (N-hBMSC) is vital for modeling the CLL niche.
Purpose of the Study:
- To compare and analyze CLL-hBMSC and N-hBMSC.
- To provide theoretical evidence for establishing a CLL-hBMSC interaction model.
- To investigate the role of LTβR-NF-κB signaling in CLL-hBMSC and N-hBMSC.
Main Methods:
- Isolation and culture of hBMSC from CLL patients and healthy donors.
- Analysis of mRNA expression for adhesion molecules (VCAM-1, ICAM-1) and LTβR using real-time PCR.
- Determination of LTβR and NF-κB family member protein expression via Western blot.
- Assessment of CLL cell survival using flow cytometry.
Main Results:
- Successful establishment of CLL-hBMSC, showing similarities to N-hBMSC.
- Comparable mRNA expression of adhesion molecules and LTβR between CLL-hBMSC and N-hBMSC.
- Similar protein expression levels of NF-κB family members and similar activation patterns upon LTα1β2 stimulation.
- No significant difference in the capacity of CLL-hBMSC and N-hBMSC to protect CLL cell survival.
Conclusions:
- There is no statistical difference in the efficiency of generating hBMSC from healthy donors versus CLL patients.
- LTβR-NF-κB signaling molecules are expressed and activated similarly in both CLL-hBMSC and N-hBMSC.
- The findings suggest that hBMSC from CLL patients and healthy donors create comparable microenvironments for CLL cells.

